The DNA microarray market was USD 1,982.1 million in 2023, and it will increase to USD 3,930.8 million, with a 10.5% compound annual growth rate, by 2030.
This is because of the rise in the occurrence of cancer across the globe, rising use of this technology in its findings, and advancements in information technology, including software.
DNA microarray has numerous applications, including disease diagnosis & monitoring, agricultural biotechnology, protein expression & proteomics, discovery of novel medication molecules, and cancer diagnosis. The increasing funding for research purposes and the rising utilization of this technology in gene expression also boosts the industry expansion.
North America led the industry in 2023, with approximately 40% share, and the regional industry will further propel at a robust rate in the years to come. This can be mainly because of the existence of major companies in this continent and the increasing funding by them to develop technologically enhanced DNA microarray products.
APAC is expected to advance at the highest rate in the years to come. This is because of the increasing funding and contributions by both foreign and local life sciences establishments and the high incidence of cancer and various other chronic illnesses in this region.
With the mounting prevalence of cancer all across the globe, the DNA microarray industry will continue to grow in the years to come.
